| 1 |
32300425 | Chronic Myeloid Leukemia With P190 BCR-ABL Translocation and Persistent Moderate Monocytosis: A Case Report. | 2018 Sep |
1 |
| 2 |
25897414 | Coexistence of P190 and P210 BCR/ABL transcripts in chronic myeloid leukemia blast crisis resistant to imatinib. | 2015 |
1 |
| 3 |
19748671 | Response to imatinib in a patient with chronic myeloid leukemia simultaneously expressing p190(BCR-ABL) oncoprotein and JAK2V617F mutation. | 2010 Jan |
1 |
| 4 |
19091403 | Molecular response to imatinib in patient with Ph negative p190 BCR-ABL transcript positive chronic myeloid leukemia with cyclic leukocytosis. | 2009 Jun |
2 |
| 5 |
16707466 | Resistance to imatinib of bcr/abl p190 lymphoblastic leukemia cells. | 2006 May 15 |
1 |
| 6 |
15949566 | Coexistence of different clonal populations harboring the b3a2 (p210) and e1a2 (p190) BCR-ABL1 fusion transcripts in chronic myelogenous leukemia resistant to imatinib. | 2005 Jul 1 |
2 |
| 7 |
16078266 | AMN107, a novel aminopyrimidine inhibitor of p190 Bcr-Abl activation and of in vitro proliferation of Philadelphia-positive acute lymphoblastic leukemia cells. | 2005 Sep 15 |
1 |
| 8 |
15650267 | Rational approaches to the design of therapeutics targeting molecular markers: the case of chronic myelogenous leukemia. | 2004 Dec |
1 |
| 9 |
11234890 | Cotreatment with STI-571 enhances tumor necrosis factor alpha-related apoptosis-inducing ligand (TRAIL or apo-2L)-induced apoptosis of Bcr-Abl-positive human acute leukemia cells. | 2001 Feb |
1 |